191 related articles for article (PubMed ID: 11435345)
1. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy.
Zou Y; Hiroi Y; Uozumi H; Takimoto E; Toko H; Zhu W; Kudoh S; Mizukami M; Shimoyama M; Shibasaki F; Nagai R; Yazaki Y; Komuro I
Circulation; 2001 Jul; 104(1):97-101. PubMed ID: 11435345
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy.
Shimoyama M; Hayashi D; Takimoto E; Zou Y; Oka T; Uozumi H; Kudoh S; Shibasaki F; Yazaki Y; Nagai R; Komuro I
Circulation; 1999 Dec; 100(24):2449-54. PubMed ID: 10595959
[TBL] [Abstract][Full Text] [Related]
3. Systemic heme oxygenase-1 transgenic overexpression aggravates pressure overload-induced cardiac hypertrophy in mice.
Chen C; Huo R; Tong Y; Sheng Y; Liu HB; Gao X; Nakajima O; Yang BF; Dong DL
Cell Physiol Biochem; 2011; 28(1):25-32. PubMed ID: 21865845
[TBL] [Abstract][Full Text] [Related]
4. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
5. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice.
Harada K; Komuro I; Shiojima I; Hayashi D; Kudoh S; Mizuno T; Kijima K; Matsubara H; Sugaya T; Murakami K; Yazaki Y
Circulation; 1998 May; 97(19):1952-9. PubMed ID: 9609089
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.
Lim HW; De Windt LJ; Steinberg L; Taigen T; Witt SA; Kimball TR; Molkentin JD
Circulation; 2000 May; 101(20):2431-7. PubMed ID: 10821822
[TBL] [Abstract][Full Text] [Related]
7. Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy.
Zou Y; Liang Y; Gong H; Zhou N; Ma H; Guan A; Sun A; Wang P; Niu Y; Jiang H; Takano H; Toko H; Yao A; Takeshima H; Akazawa H; Shiojima I; Wang Y; Komuro I; Ge J
Hypertension; 2011 Dec; 58(6):1099-110. PubMed ID: 21986507
[TBL] [Abstract][Full Text] [Related]
8. gp130 plays a critical role in pressure overload-induced cardiac hypertrophy.
Uozumi H; Hiroi Y; Zou Y; Takimoto E; Toko H; Niu P; Shimoyama M; Yazaki Y; Nagai R; Komuro I
J Biol Chem; 2001 Jun; 276(25):23115-9. PubMed ID: 11262406
[TBL] [Abstract][Full Text] [Related]
9. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
[TBL] [Abstract][Full Text] [Related]
10. Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis.
Xu Q; Lekgabe ED; Gao XM; Ming Z; Tregear GW; Dart AM; Bathgate RA; Samuel CS; Du XJ
Endocrinology; 2008 Feb; 149(2):476-82. PubMed ID: 17991721
[TBL] [Abstract][Full Text] [Related]
11. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
Yamamoto K; Ohishi M; Katsuya T; Ito N; Ikushima M; Kaibe M; Tatara Y; Shiota A; Sugano S; Takeda S; Rakugi H; Ogihara T
Hypertension; 2006 Apr; 47(4):718-26. PubMed ID: 16505206
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension.
Shimoyama M; Hayashi D; Zou Y; Takimoto E; Mizukami M; Monzen K; Kudoh S; Hiroi Y; Yazaki Y; Nagai R; Komuro I
Circulation; 2000 Oct; 102(16):1996-2004. PubMed ID: 11034951
[TBL] [Abstract][Full Text] [Related]
13. Roles of calcineurin and calcium/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy.
Saito T; Fukuzawa J; Osaki J; Sakuragi H; Yao N; Haneda T; Fujino T; Wakamiya N; Kikuchi K; Hasebe N
J Mol Cell Cardiol; 2003 Sep; 35(9):1153-60. PubMed ID: 12967638
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function.
Hill JA; Rothermel B; Yoo KD; Cabuay B; Demetroulis E; Weiss RM; Kutschke W; Bassel-Duby R; Williams RS
J Biol Chem; 2002 Mar; 277(12):10251-5. PubMed ID: 11786544
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.
Esposito G; Rapacciuolo A; Naga Prasad SV; Takaoka H; Thomas SA; Koch WJ; Rockman HA
Circulation; 2002 Jan; 105(1):85-92. PubMed ID: 11772881
[TBL] [Abstract][Full Text] [Related]
16. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
17. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
[TBL] [Abstract][Full Text] [Related]
18. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
[TBL] [Abstract][Full Text] [Related]
19. Diacylglycerol kinase zeta attenuates pressure overload-induced cardiac hypertrophy.
Harada M; Takeishi Y; Arimoto T; Niizeki T; Kitahara T; Goto K; Walsh RA; Kubota I
Circ J; 2007 Feb; 71(2):276-82. PubMed ID: 17251681
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.
Takeda Y; Yoneda T; Demura M; Usukura M; Mabuchi H
Circulation; 2002 Feb; 105(6):677-9. PubMed ID: 11839620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
